NCT03544996View on ClinicalTrials.gov

Transdermally Delivered Human Insulin Product

CompletedOBSERVATIONAL
Enrollment

1

Participants

Timeline

Start Date

September 9, 2017

Primary Completion Date

February 4, 2018

Study Completion Date

February 4, 2018

Conditions
Hypoinsulinemia
Interventions
COMBINATION_PRODUCT

TD Insulin

Human Insulin USP formulated in a solution capable of transdermal delivery.

Trial Locations (1)

33410

Langford Research Institute, Palm Beach Gardens

All Listed Sponsors
lead

Transdermal Delivery Solutions Corp

INDUSTRY

NCT03544996 - Transdermally Delivered Human Insulin Product | Biotech Hunter | Biotech Hunter